{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-227025","form_type":"8-K","ticker":"CLYM","cik":"0001768446","company_name":"Climb Bio, Inc.","filed_at":"2025-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.368752+00:00","generated_at":"2026-05-17T05:06:29.129917+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Climb Bio appoints Susan Altschuller as CFO, grants 600,000 stock options","bullets":["Appointed Susan Altschuller, Ph.D., MBA, as CFO and Treasurer effective Oct 1, 2025; previously CFO at Cerevel and ImmunoGen.","Base salary $510,000/year; eligible for annual bonus up to 40% of base.","Received option to purchase 600,000 shares under 2025 Inducement Plan; vesting 25% on one-year anniversary then monthly.","Board amended Inducement Plan to increase reserved shares from 1.25M to 2.0M.","Cindy Driscoll steps down as principal financial officer but continues as principal accounting officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-227025","json":"https://secwatch.observer/filing/0001193125-25-227025.json","markdown":"https://secwatch.observer/filing/0001193125-25-227025.md","text":"https://secwatch.observer/filing/0001193125-25-227025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525227025/0001193125-25-227025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1768446/000119312525227025/d33819d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:06:29.129917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}